Test Price
2,800 AED✅ Home Collection Available
ECM1 Gene Analysis for Urbach-Wiethe Disease – Next-Generation Sequencing (Genetic Test in UAE | 2800 AED | DHA Licensed)
Executive Summary & Core Metrics
- ✓ 99.9% Diagnostic Sensitivity – ISO‑accredited NGS analysis with full gene coverage and variant interpretation aligned with ACMG guidelines.
- ✓ Premium Home Collection – Hospital‑grade phlebotomy via ISO‑certified cold‑chain logistics, available 8 AM–11 PM across the UAE.
- ✓ Post‑Test Clinical Guidance – Telephonic consultation with a DHA‑licensed genetic counsellor to interpret your NGS report.
- ✓ Insurance Support – Direct billing verification via WhatsApp at +971 54 548 8731.
This definitive genetic test provides comprehensive analysis of the ECM1 gene to diagnose Urbach-Wiethe disease (lipoid proteinosis) using advanced next-generation sequencing. It empowers clinicians, geneticists, and families with precise molecular diagnosis and carrier status determination, fully compliant with UAE healthcare regulations.
Test Overview & Methodology
The ECM1 gene NGS test screens the entire coding region for pathogenic variants causing Urbach‑Wiethe disease, a rare autosomal recessive disorder. This test empowers clinicians, geneticists, and families with definitive molecular diagnosis and carrier status determination.
| Feature | Our Genetic Test | Conventional Single‑Gene Testing |
|---|---|---|
| Methodology | Full‑gene Next‑Generation Sequencing (Illumina platform) | Sanger sequencing – limited to known hotspots |
| Variant Detection | SNVs, indels, copy number changes – all exons ±20bp splice sites | Only targeted point mutations |
| Turnaround Time | 3–4 weeks with comprehensive clinical report | 6–8 weeks, often without CNV analysis |
| Clinical Utility | Full differential – distinguishes lipoid proteinosis from mimicking disorders | May miss atypical mutations, leading to false negatives |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I consider this NGS test the gold standard for confirming Urbach‑Wiethe disease. However, genetic results must be correlated with clinical findings—hoarseness, skin beading, and neuroimaging. No single lab value defines prognosis; multidisciplinary follow‑up is essential. This test is part of a comprehensive diagnostic pathway, not a standalone answer.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA License: 9294403)
Advisory – Genetic Counselling Requirement
Pre- and post-test genetic counselling is mandatory for this test. A DHA‑licensed genetic counsellor will discuss implications for the patient and family members, including carrier risk and reproductive options. This session can be conducted via telemedicine prior to sample collection.
Exclusion Criteria & Safety Red Flags
- Exclusion Criteria: Individuals with unstable psychiatric conditions that may impair understanding of genetic implications, or those unable to provide informed consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Post‑Collection Emergency: If you experience severe dizziness, fainting, or signs of infection at the draw site, seek immediate medical attention.
- Result Interpretation: A positive result is not a diagnosis in isolation – follow‑up with a clinical geneticist is mandatory.
Patient FAQ & Clinical Guidance
1. How reliable is the Genetic Test for detecting Urbach‑Wiethe disease?
Our full‑gene sequencing achieves over 99.9% analytical sensitivity and specificity, detecting nearly all pathogenic single‑nucleotide variants and exon‑level deletions. This makes it the most comprehensive molecular diagnostic tool for lipoid proteinosis, validated according to ISO 9001:2015 and DHA proficiency testing standards.
2. Does the test cover all genetic variants linked to Urbach‑Wiethe disease?
The analysis covers all exons and splice sites of the ECM1 gene, detecting over 98% of known pathogenic mutations. Rare deep‑intronic or regulatory variants may require additional investigation, but the current coverage is the highest clinically available.
3. What is the sample required, and can it be collected at home?
A simple blood draw, extracted DNA, or a single drop of blood on an FTA card is sufficient – we offer VIP home collection across the UAE. Our phlebotomists bring cold‑chain transport and can perform the draw within 60 minutes of booking. Pre‑test genetic counselling (tele‑session available) is required to map your family pedigree and ensure informed consent.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This test and its associated data handling comply with the following UAE federal laws:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring genetic data privacy and secure processing.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health records and telemedicine.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – safeguarding patient consent and clinical accountability.
All genetic data is stored on DHA‑licensed encrypted servers within the UAE, with access restricted to authorized healthcare professionals.
Clinical & Logistical Metadata
| Test Name | ECM1 Gene Analysis for Urbach-Wiethe Disease (Next-Generation Sequencing) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood (Venipuncture) – Home Collection Available |
| Methodology Used | Next-Generation Sequencing (NGS) – Whole Gene Analysis |
| ICD-10-CM Code | E78.89 |
| LOINC Code | 94850-1 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians